As ATM inhibitors have now entered clinical trials with radiation therapy for adults with brain tumors or brain metastases (NCT03423628), our results suggest correlation of TP53 status and PTEN pathway mutational status will be important to include in any future clinical trials of ATM inhibitors with radiation therapy in brainstem gliomas. Here, TP53 is linked to brain neoplasm.